尿毒症患者铁代谢相关指标检测的研究进展

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract The late stage of chronic renal failure is uremia，the main laboratory tests of uremia such as urea nitrogen，creatinine are often only able to reflect the degree of disease progression and dialysis effect.Uremic patients are often accompanied by anemia caused by abnormal ironmetabolism and severe anemia will greatly affect the quality of life of patients and even the long-term survival of patients，so uremic patients often need to carry out some of the detection of iron metabolism related indicators to guide clinicians tomake up iron in time in order to correct anemia and improve the quality of life of patients.At present，themain indexes of ironmetabolism are serum iron，total iron binding capacity，serum ferritin.In recent years，a new type of iron regulatory protein　（hepcidin）has been discovered.Subsequently，more and more studies showed that hepcidin is an important factor in the level of iron metabolism in uremic hemodialysis patients.This papermainly from the perspective of laboratory testing reviews the basic theory of uremia disease and the commonly used laboratory tests，at the same time investigates the correlation indexes of ironmetabolism and the important role of iron in the patientswith uremia.

Key words： Uremia Ironmetabolism Indicators

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GAO Hui-shuang
	YE Fang

Cite this article:

GAO Hui-shuang,YE Fang. Research progress on detection of iron metabolism related indexes in urem ic patients[J]. 中国当代医药, 2016, 23(20): 15-17.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2016/V23/I20/15

［1］	Gilmore J.KDOQI clinical practice guidelines and clinical practice recommendations--2006 updates［J］.Nephrol Nurs J，2006，33（5）：487-488.
［2］	葛均波，徐永健.内科学［M］.8版.北京：人民卫生出版社，2013.
［3］	杨慧.检验指标对慢性肾功能衰竭患者的临床观察［J］.中国保健营养（上旬刊），2013，（10）：5485.
［4］	张金锋，李雪云，高金枝，等.维持性血液透析对尿毒症患者心瓣膜钙化、胎球蛋白A和CRP水平的影响［J］.中国卫生检验杂志，2015，（17）：2928-2930.
［5］	戴建芳，张益红，胡玲玲，等.维持性血液透析患者血常规、钙、磷、甲状旁腺激素检测指标的调查分析［J］.检验医学与临床，2012，9（22）：2792-2793.
［6］	Drüeke TB，Eckardt KU.Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients［J］.Nephrol Dial Transplant，2002，17（Suppl 5）：28-31.
［7］	何惠，刘基铎，石良招.慢性肾功能衰竭患者贫血与铁原料关系探讨［J］.现代中西医结合杂志，2006，15（20）：2774-2775.
［8］	Koo HM，Kim CH，Doh FM，et al.The relationship of initial transferrin saturation to cardiovascular parameters and outcomes in patients initiating dialysis［J］.PLoS One，2014，9 （2）：e87231.
［9］	Krause A，Neitz S，Mägert HJ，et al.LEAP-1，a novel highly disulfide-bonded human peptide，exhibits antimicrobial activity［J］.FEBSLett，2000，480（2-3）：147-150.
［10］	Park CH，Valore EV，Waring AJ，et al.Hepcidin，a urinary antimicrobialpeptidesynthesized in the liver［J］.JBiolChem，2001，276（11）：7806-7810.
［11］	Malyszko J，Malyszko JS，Pawlak K，et al.Hepcidin，iron status，and renal function in chronic renal failure，kidney transplantation，and hemodialysis［J］.Am JHematol，2006，81（11）：832-837.
［12］	袁群生，刘鹏举，郑法雷.铁调素对慢性肾脏病患者铁代谢的调节作用及其机制［J］.中国血液净化，2010，9（9）：473-476.
［13］	Shoji S，Inaba M，Tomosugi N，et al.Greater potency of darbepoetin-α　than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythro poiesis in hemodialysis patients［J］.Eur JHaematol，2013，90（3）：237-244.
［14］	Sasu B，Cooke KS，Arvedson TL，et al.Antihepcidin antibody treatmentmodulates iron metabolism and is effective in a mouse model of inflammation-induced anemia［J］. Blood，2010，115（17）：3616-3624.
［15］	Cooke KS，Hinkle B，Salimi-Moosavi H，et al.A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates［J］.Blood，2013，122 （17）：3054-3061.
［16］	Peyssonnaux C，Zinkernagel AS，Schuepbach RA，et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors（HIFs）［J］.JClin Invest，2007，117（7）：1926-1932.
［17］	张妍，周晓玲，陈孟华.终末期肾脏病患者血清中铁调素的水平变化及其与铁代谢的关系［J］.中国血液净化，2011，10（7）：371-375.